Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

676
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
676
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

635
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
635
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

758
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
758
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

644
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
644
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

2.0K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing a cirrhosis order set in a tertiary healthcare system: a theory-informed formative evaluation.

BMC health services research·2023
Same author

Inter-Bragg crystallographic phase retrieval from shape transforms, stacking faults and substitutional disorder.

Ultramicroscopy·2023
Same author

Joint iterative reconstruction and 3D rigid alignment for X-ray tomography.

Optics express·2022
Same author

The risk of diarrhea and colitis in patients with lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

Current oncology (Toronto, Ont.)·2020
Same author

What is the Quality of Life of Transtibial Amputees in Brunei Darussalam?

Malaysian orthopaedic journal·2020
Same author

Beta-blockers in hospitalised patients with cirrhosis and ascites: mortality and factors determining discontinuation and reinitiation.

Alimentary pharmacology & therapeutics·2017

Related Experiment Video

Updated: Mar 31, 2026

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
08:22

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Published on: December 22, 2023

1.2K

Substituted triazoles as anti-inflammatory agents.

K Pande, P Tandon, T N Bhalla

    Research Communications in Chemical Pathology and Pharmacology
    |September 1, 1984
    PubMed
    Summary

    Newly developed triazole compounds show strong anti-inflammatory and antiproteolytic effects. These novel agents also exhibit reduced toxicity, offering a promising therapeutic profile.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology

    Background:

    • Inflammation and proteolysis are key pathological processes in various diseases.
    • Developing effective and safe anti-inflammatory and antiproteolytic agents remains a significant challenge.

    Purpose of the Study:

    • To synthesize and evaluate novel triazole derivatives for their anti-inflammatory and antiproteolytic potential.
    • To assess the safety profile of the newly synthesized compounds.

    Main Methods:

    • Synthesis of novel triazole derivatives.
    • In vitro assays to determine anti-inflammatory activity.
    • In vitro assays to determine antiproteolytic activity.
    • Toxicity assessments.

    Main Results:

    More Related Videos

    Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
    04:47

    Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

    Published on: October 27, 2023

    2.1K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.9K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
    08:22

    Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

    Published on: December 22, 2023

    1.2K
    Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice
    04:47

    Author Spotlight: Evaluating Traditional Chinese Therapy for Ankylosing Spondylitis in Mice

    Published on: October 27, 2023

    2.1K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.9K
  • The newly synthesized triazole derivatives demonstrated potent anti-inflammatory activity.
  • These compounds also exhibited significant antiproteolytic effects.
  • The evaluated triazole derivatives showed relatively low toxicity.

    • Conclusions:

    • Novel triazole derivatives possess significant anti-inflammatory and antiproteolytic properties.
    • These compounds represent a promising class of therapeutic agents with a favorable safety margin.